Gene · 3675
Papers2,788
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 2,788
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Exosomes in Epithelial-Mesenchymal Transition. | ACS Appl Bio Mater | 2024 | 38108852 | PubTator, text mining | PubMed |
| The prognostic power of gene mutations in thyroid cancer. | Endocr Connect | 2024 | 38078934 | PubTator, text mining | PubMed |
| Ex vivo hematopoietic stem cell expansion technologies: recent progress, applications, and open questions. | Exp Hematol | 2024 | 38072133 | PubTator, text mining | PubMed |
| Expression pattern of osteopontin isoforms in malignant melanoma cell lines. | Clin Transl Sci | 2024 | 38058256 | PubTator, text mining | PubMed |
| FTO Knockdown-Mediated Maturation of miR-383-5p Inhibits Malignant Advancement of Pancreatic Cancer by Targeting ITGA3. | Biochem Genet | 2024 | 38001392 | PubTator, text mining | PubMed |
| VPS35 promotes gastric cancer progression through integrin/FAK/SRC signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner. | Oncogene | 2024 | 37950040 | PubTator, text mining | PubMed |
| Integrin αvβ1 facilitates ACE2-mediated entry of SARS-CoV-2. | Virus Res | 2024 | 37884208 | PubTator, text mining | PubMed |
| Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens. | Life Sci Alliance | 2024 | 37863651 | PubTator, text mining | PubMed |
| Insight into the mechanism of CD34+ cell mobilisation impairment in multiple myeloma patients treated with anti-CD38 therapy. | Br J Haematol | 2024 | 37807708 | PubTator, text mining | PubMed |
| Integrative proteomics and n-glycoproteomics reveal the synergistic anti-tumor effects of aspirin- and gemcitabine-based chemotherapy on pancreatic cancer cells. | Cell Oncol (Dordr) | 2024 | 37639207 | PubTator, text mining | PubMed |
| Effects of microenvironment and biological behavior on the paracrine function of stem cells. | Genes Dis | 2024 | 37588208 | PubTator, text mining | PubMed |
| Identification of potential hub genes associated with atopic dermatitis-like recombinant human epidermal model using integrated transcriptomic and proteomic analysis. | Biomol Biomed | 2024 | 37540585 | PubTator, text mining | PubMed |
| A novel gene signature related to focal adhesions for distinguishing and predicting the prognosis of lung squamous cell carcinoma. | Front Med (Lausanne) | 2023 | 38259849 | PubTator, text mining | PubMed |
| Vdelta1 T cells are more resistant than Vdelta2 T cells to the immunosuppressive properties of galectin-3. | Front Immunol | 2023 | 38259448 | PubTator, text mining | PubMed |
| The Potential of Extracellular Matrix- and Integrin Adhesion Complex-Related Molecules for Prostate Cancer Biomarker Discovery. | Biomedicines | 2023 | 38255186 | PubTator, text mining | PubMed |
| Different Transcriptome Features of Peripheral Blood Mononuclear Cells in Non-Emphysematous Chronic Obstructive Pulmonary Disease. | Int J Mol Sci | 2023 | 38203236 | PubTator, text mining | PubMed |
| CD49f and CD146: A Possible Crosstalk Modulates Adipogenic Differentiation Potential of Mesenchymal Stem Cells. | Cells | 2023 | 38201259 | PubTator, text mining | PubMed |
| Extracellular molecular signals shaping dendrite architecture during brain development. | Front Cell Dev Biol | 2023 | 38155836 | PubTator, text mining | PubMed |
| Impact of MICA 3'UTR allelic variability on miRNA binding prediction, a bioinformatic approach. | Front Genet | 2023 | 38146340 | PubTator, text mining | PubMed |
| Exploration and validation of key genes associated with early lymph node metastasis in thyroid carcinoma using weighted gene co-expression network analysis and machine learning. | Front Endocrinol (Lausanne) | 2023 | 38144565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3675/papers?page=10